Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q7TO
|
|||
| Former ID |
DIB019953
|
|||
| Drug Name |
K00244
|
|||
| Synonyms |
GSK-3 Inhibitor XIII; N-(5-methyl-1H-pyrazol-3-yl)-2-phenylquinazolin-4-amine; GSK3-XIII; K00244; 404828-08-6; CHEMBL359482; (5-Methyl-1H-pyrazol-3-yl)-(2-phenylquinazolin-4-yl)amine; CHEBI:78544; AC1O4WD1; SCHEMBL462877; GTPL5976; CTK4I3154; HMS3229I06; BDBM228657; BCP12434; BDBM50162083; ZINC16052235; IN1311; AKOS025394676; DB08454; CCG-101293; NCGC00387776-01; ACM404828086; RT-013126; N-(3-methyl-1H-pyrazol-5-yl)-2-phenylquinazolin-4-amine; (5-Methyl-1H-pyrazol-3-yl)-(2-phenyl-quinazolin-4-yl)-amine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C18H15N5
|
|||
| Canonical SMILES |
CC1=CC(=NN1)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4
|
|||
| InChI |
1S/C18H15N5/c1-12-11-16(23-22-12)20-18-14-9-5-6-10-15(14)19-17(21-18)13-7-3-2-4-8-13/h2-11H,1H3,(H2,19,20,21,22,23)
|
|||
| InChIKey |
JYCUVOXSZBECAY-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
10318996, 11618429, 14845469, 16291188, 26716740, 26758808, 43014032, 51258861, 53800751, 99302736, 99444925, 103441262, 104048292, 114518104, 124659180, 137245136, 137275057, 140243665, 160969491, 162851471, 163688035, 178102599, 180372395, 204371601, 208264967, 223443870, 226781412, 241081272, 245750568, 249119794
|
|||
| ChEBI ID |
CHEBI:78544
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The discovery of the potent aurora inhibitor MK-0457 (VX-680). Bioorg Med Chem Lett. 2009 Jul 1;19(13):3586-92. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.